Q3 2024 Holdings
Filed 2024-11-14 | 116 holdings | $628.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $38.4M | 2,130,216 | 6.1% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $23.6M | 409,515 | 3.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $21.5M | 842,644 | 3.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $19.9M | 1,034,846 | 3.2% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $19.7M | 105,607 | 3.1% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $16.8M | 29,316 | 2.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.7M | 125,846 | 2.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $14.8M | 190,060 | 2.4% |
| Microsoft Corp(MSFT) | COM | 594918104 | $14.4M | 33,427 | 2.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $14.2M | 419,103 | 2.3% |
| Apple Inc(AAPL) | COM | 037833100 | $14.2M | 60,847 | 2.3% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $13.6M | 78,361 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $11.9M | 610,087 | 1.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $11.9M | 225,021 | 1.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $11.7M | 13,190 | 1.9% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $11.3M | 69,831 | 1.8% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $10.9M | 195,349 | 1.7% |
| Nova LTD(NVMI) | COM | M7516K103 | $10.8M | 51,960 | 1.7% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $9.3M | 78,080 | 1.5% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $9.3M | 209,441 | 1.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $8.8M | 152,307 | 1.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $8.4M | 133,066 | 1.3% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $8.3M | 933,225 | 1.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $8.2M | 721,111 | 1.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $8.1M | 439,292 | 1.3% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $7.9M | 589,295 | 1.3% |
| Check Point Software Tech LT(CHKP) | ORD | M22465104 | $7.8M | 40,215 | 1.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $7.5M | 38,000 | 1.2% |
| Merus N V | COM | N5749R100 | $7.4M | 147,633 | 1.2% |
| Enphase Energy Inc(ENPH) | COM | 29355A107 | $7.3M | 64,224 | 1.2% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $6.8M | 59,600 | 1.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $6.7M | 133,323 | 1.1% |
| Sentinelone Inc(S) | CL A | 81730H109 | $6.6M | 276,554 | 1.1% |
| Marvell Technology Inc(MRVL) | COM | 573874104 | $6.3M | 87,611 | 1.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $6.2M | 1,191,140 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.2M | 215,873 | 1.0% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $6.1M | 1,563,522 | 1.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $6.0M | 291,080 | 1.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $5.8M | 1,196,938 | 0.9% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $5.8M | 50,000 | 0.9% |
| WIX COM LTD(WIX) | SHS | M98068105 | $5.7M | 34,253 | 0.9% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $5.6M | 1,647,604 | 0.9% |
| Nice LTD(NSY)Call | SPONSORED ADR | 653656108 | $5.6M | 32,100 | 0.9% |
| Ormat Technologies Inc | DEBT 2.500% 7/1 | 686688AC6 | $5.3M | 5,037,000 | 0.8% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $4.8M | 347,627 | 0.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.7M | 24,455 | 0.8% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $4.4M | 118,345 | 0.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.3M | 231,792 | 0.7% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $4.1M | 100,000 | 0.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.0M | 536,547 | 0.6% |